Beyond LDL: Unlocking Your True Heart Risk

Apolipoprotein B (ApoB) is a protein found on cholesterol and fat-carrying particles in the blood, and its levels are increasingly recognized as a vital indicator of heart disease risk. High ApoB levels are directly linked to an elevated risk of heart attacks and strokes, even when traditional LDL or "bad" cholesterol numbers appear normal. This protein plays a role in forming plaque in arteries, which can lead to blockages and serious cardiovascular events.

Factors contributing to high ApoB levels include genetics, insulin resistance, high triglycerides, unhealthy dietary habits, lack of exercise, obesity, hypothyroidism, kidney disease, steroid use, and smoking. Certain medications may also influence ApoB levels. Fortunately, many strategies proven to lower LDL cholesterol are also effective for reducing ApoB. These include adopting a Mediterranean diet, limiting saturated fats, regular physical activity, maintaining a healthy weight, and moderating alcohol intake.

In addition to lifestyle modifications, medications such as statins, PCSK9 inhibitors, and bempedoic acid are instrumental in lowering both LDL and ApoB. While standard cholesterol panels are sufficient for many, an ApoB test can provide critical insights for individuals with high triglycerides, diabetes, metabolic syndrome, fatty liver disease, or a family history of early heart disease. Consulting a healthcare professional is recommended to determine if ApoB testing is appropriate.